Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis
- 2 May 2010
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 411 (9-10) , 710-713
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progressionAutoimmunity Reviews, 2009
- Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISARheumatology, 2008
- Nucleolar staining cannot be used as a screening test for the scleroderma marker anti–RNA polymerase I/III antibodiesArthritis & Rheumatism, 2006
- Enzyme‐linked immunosorbent assay for detection of Anti–RNA polymerase III antibody: Analytical accuracy and clinical associations in systemic sclerosisArthritis & Rheumatism, 2005
- Scleroderma?clinical and pathological advancesBest Practice & Research Clinical Rheumatology, 2004
- Evidence‐based guidelines for the use of immunologic tests: Anticentromere, Scl‐70, and nucleolar antibodiesArthritis Care & Research, 2003
- Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysisArthritis & Rheumatism, 1996
- Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1988
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988
- Fibrillarin: a new protein of the nucleolus identified by autoimmune seraBiology of the Cell, 1985